Nathan Pennell, M.D., Ph.D.
| Appointed: |
2008 |
| Gender: |
Male |
| Languages: |
English |
Solid Tumor Oncology
Biographical Sketch
Dr. Pennell is a board certified medical oncologist who joined the staff of the Taussig Cancer Center in 2008. He specializes in the treatment of thoracic malignancies with a focus on lung cancer.
Dr. Pennell's research interests include clinical trials using novel therapies, with a goal of facilitating the movement of new treatments from the laboratory to the clinic.
He received his Ph.D. in neuroscience in 1998 and his M.D. in 2002 from the University of Florida College of Medicine in Gainesville, FL.
Dr. Pennell completed his internal medicine residency in 2005 at Brigham and Women's Hospital in Boston, MA. His medical oncology fellowship training was completed in 2007 at the Dana Farber Cancer Institute.
Education & Fellowships
| Medical School: | University of Florida College of Medicine, Gainesville, FL |
|
| Internship: | Brigham & Women's Hospital, Internal Medicine, Boston, MA |
| Residency: | Brigham & Women's Hospital, Internal Medicine, Boston, MA |
| Fellowship: | Dana-Farber Cancer Institute, Medical Oncology, Boston, MA |
| Other Education: | (Doctorate) University of Florida College of Medicine, Gainesville, FL |
| Other Education: | (Undergraduate) University of North Carolina at Chapel Hill, Chapel Hill, NC |
Additional Training
Program in Clinical Effectiveness, Harvard School of Public Health, 2006
Certifications
Medical Oncology
Internal Medicine
Specialty Interests
Lung cancer, thyroid cancer, mesothelioma, clinical trials.
Professional Memberships
- American Society of Clinical Oncology
- International Association for the Study of Lung Cancer
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/14/2008, Dr. Pennell has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Pennell receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
